Insmed (INSM) Gross Profit (2018 - 2026)
Insmed's Gross Profit was $358.27 million in Q2 2026, up 351.6% from $79.34 million a year earlier and up 38.6% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Gross Profit (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Insmed's Gross Profit was $949.42 million through Jun 30, 2026, up 215.0% year-over-year; for FY2025, it came in at $483.49 million, up 73.9% from FY2024.
- Gross Profit has now increased for six consecutive years, with a five-year compound annual growth rate of 31.2% (FY2020 to FY2025).
- In earlier years, Gross Profit was $277.97 million in FY2024 (+16.0%), $239.64 million in FY2023 (+26.0%), $190.23 million in FY2022 (+31.8%) and $144.31 million in FY2021 (+15.9%).
- The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q4 2018.
- Compared with a year earlier, Gross Profit has increased for 22 straight quarters, with growth averaging 115.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Gross Profit ranged from 7.9% (Q4 2022) to 351.6% (Q2 2026).
- Per Business Quant data, INSM's Gross Profit in the three quarters before Q2 2026 was $258.54 million (Q1 2026), $219.62 million (Q4 2025) and $112.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Insmed | 24.26 Bn | 18.76 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 358.27 Mn |
| Mar 31, 2026 | 258.54 Mn |
| Dec 31, 2025 | 219.62 Mn |
| Sep 30, 2025 | 112.98 Mn |
| Jun 30, 2025 | 79.34 Mn |
| Mar 31, 2025 | 71.55 Mn |
| Dec 31, 2024 | 78.29 Mn |
| Sep 30, 2024 | 72.26 Mn |
| Jun 30, 2024 | 69.38 Mn |
| Mar 31, 2024 | 58.04 Mn |
| Dec 31, 2023 | 65.25 Mn |
| Sep 30, 2023 | 62.37 Mn |
| Jun 30, 2023 | 60.64 Mn |
| Mar 31, 2023 | 51.38 Mn |
| Dec 31, 2022 | 46.23 Mn |
| Sep 30, 2022 | 54.26 Mn |
| Jun 30, 2022 | 48.83 Mn |
| Mar 31, 2022 | 40.92 Mn |
| Dec 31, 2021 | 42.84 Mn |
| Sep 30, 2021 | 36.57 Mn |
API Access
Insmed Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();